Pancreatic Cancer Research

Clinical trialObservationalRecruiting

PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma

PaCaReg: A Multicenter Registry Trial for the Assessement of Clinical, Epidemiological and Biological Profiles in Patients With Pancreatic Ductal Adenocarcinoma

Outcome
Ongoing
Phase
Observational
Status
Recruiting
Study type
Observational
Start
10 October 2018
Expected end
October 2029
Enrollment
5,000 participants
Sites
1
Primary outcomes
General assessment of applied therapy modalities in pancreatic cancer; Quality of life in pancreatic cancer patients
Sponsor type
Academic / other
Results posted
No
Last update
25 September 2019

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma